TERT - Telomerase Reverse Transcriptase| Elisa - Clia - Antibody - Protein

Background

Telomerase Reverse Transcriptase (TERT) is a catalytic subunit of the enzyme telomerase, which is critical for maintaining telomere length and genomic stability. TERT is encoded by the TERT gene located on chromosome 5p15.33. Telomeres are repetitive nucleotide sequences (TTAGGG in humans) at the ends of chromosomes that protect them from degradation and fusion with neighboring chromosomes. TERT, in conjunction with the RNA component of telomerase (TERC), synthesizes telomeric DNA repeats onto chromosome ends. This activity counteracts the progressive shortening of telomeres that occurs during cell division. TERT is highly active in stem cells, germ cells, and cancer cells but is typically repressed in most somatic cells, leading to progressive telomere shortening and eventual cell senescence or apoptosis.

Protein Structure

TERT is a large protein with several key structural domains:

• Telomerase RNA-Binding Domain (TRBD): This domain binds to TERC, the RNA component of telomerase, which serves as a template for telomere extension.
• Reverse Transcriptase Domain: Responsible for the enzymatic activity of TERT, this domain catalyzes the addition of nucleotide sequences to the telomere ends.
• Telomerase Essential N-terminal (TEN) Domain: This domain aids in the proper assembly and function of the telomerase complex.
• C-terminal Extension (CTE): Plays a role in the regulation and stabilization of the enzyme.

Classification and Subtypes

TERT is classified as a reverse transcriptase enzyme. Although it does not have subtypes, its activity and regulation can vary significantly across different cell types and conditions, such as cancer versus normal somatic cells.

Function and Biological Significance

TERT serves several critical functions:

• Telomere Elongation: TERT adds telomeric repeats to chromosome ends, counteracting telomere shortening that occurs during DNA replication.
• Genomic Stability: By maintaining telomere length, TERT prevents chromosome end-to-end fusions and genomic instability.
• Cellular Aging: Telomere shortening in somatic cells leads to cellular senescence or apoptosis, contributing to aging. TERT activity is a key factor in the aging process.
• Stem Cell Function: TERT activity is crucial in stem cells for long-term tissue regeneration and repair.
• Cancer: TERT reactivation is a hallmark of cancer, allowing cells to bypass replicative senescence and achieve limitless replicative potential.

Clinical Issues

Abnormal TERT activity is associated with several clinical conditions:

• Cancer: TERT is reactivated in approximately 85% of cancers, contributing to uncontrolled cell proliferation and tumorigenesis. Mutations in the TERT promoter region are linked to various cancers, including melanoma and glioblastoma.
• Telomere Syndromes: Mutations in the TERT gene can cause telomere syndromes such as dyskeratosis congenita, aplastic anemia, and idiopathic pulmonary fibrosis. These conditions are characterized by premature telomere shortening and associated clinical manifestations.
• Aging and Degenerative Diseases: Reduced TERT activity is associated with age-related degenerative diseases due to its role in maintaining tissue regenerative capacity.

Summary

Telomerase Reverse Transcriptase (TERT) is a crucial enzyme responsible for maintaining telomere length and ensuring genomic stability. It plays significant roles in cellular aging, stem cell function, and cancer. TERT activity is tightly regulated in somatic cells but reactivated in most cancers, making it a potential therapeutic target. Mutations and dysregulation of TERT are associated with various telomere syndromes and age-related diseases, highlighting its importance in human health and disease. Understanding TERT's mechanisms and regulation is vital for developing treatments for cancer and other telomere-related disorders.